ACT Biotech's Series A Round

ACT Biotech raised a round of funding on May 16, 2008. Investors include NGN Capital.

ACT Biotech aims to bring therapies to bear in managing cancer, especially in underserved disease sectors where patient need is acute. Per the company, ACT has launched an aggressive, focused developm…

Articles about ACT Biotech's Series A Round: